Glucotrack Stock Today
| GCTK Stock | USD 0.25 0.02 7.41% |
Performance0 of 100
| Odds Of DistressOver 81
|
GlucoTrack is selling for 0.25 as of the 21st of November 2024. This is a 7.41 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.22. GlucoTrack has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for GlucoTrack are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of April 2013 | Category Healthcare | Classification Health Care |
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel. The company has 8.21 M outstanding shares of which 37.92 K shares are currently shorted by private and institutional investors with about 6.03 trading days to cover. More on GlucoTrack
Moving together with GlucoTrack Stock
Moving against GlucoTrack Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
GlucoTrack Stock Highlights
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Management, Office Supplies, Drugs, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsGlucoTrack can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand GlucoTrack's financial leverage. It provides some insight into what part of GlucoTrack's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GlucoTrack (GCTK) is traded on NASDAQ Exchange in USA. It is located in 301 Route 17 North, Rutherford, NJ, United States, 07070 and employs 6 people. GlucoTrack is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.18 M. GlucoTrack conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 8.21 M outstanding shares of which 37.92 K shares are currently shorted by private and institutional investors with about 6.03 trading days to cover.
GlucoTrack currently holds about 3.85 M in cash with (6.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25.
Check GlucoTrack Probability Of Bankruptcy
Ownership AllocationGlucoTrack secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check GlucoTrack Ownership Details
GlucoTrack Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Alerus Financial Na | 2024-09-30 | 13.9 K | |
| Cetera Investment Advisers | 2024-06-30 | 10 K | |
| Ubs Group Ag | 2024-06-30 | 6.1 K | |
| Renaissance Technologies Corp | 2024-06-30 | 0.0 | |
| Susquehanna International Group, Llp | 2024-06-30 | 0.0 | |
| Sabby Management Llc | 2024-06-30 | 0.0 | |
| Accurate Wealth Management, Llc | 2024-06-30 | 0.0 | |
| Virtue Capital Management, Llc | 2024-06-30 | 0.0 | |
| Citadel Advisors Llc | 2024-06-30 | 0.0 |
GlucoTrack Historical Income Statement
GlucoTrack Stock Against Markets
GlucoTrack Corporate Management
| Erez BenZvi | GM Product | Profile | |
| Drinda Benjamin | Vice Marketing | Profile | |
| Paul Goode | Chief Officer | Profile | |
| MScEE MBA | Chairman CoFounder | Profile | |
| Mark Tapsak | Vice Technology | Profile | |
| Esq CPA | Chief Officer | Profile | |
| David BA | CoFounder | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GlucoTrack. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.91) | Return On Assets (1.57) | Return On Equity (5.41) |
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.